Value in Hepatitis C Virus Treatment: A Patient-Centered Cost-Effectiveness Analysis

PharmacoEconomics - United Kingdom
doi 10.1007/s40273-019-00864-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Cost-Effectiveness Analysis of Antiviral Pharmacotherapies for Treatment of Chronic Hepatitis C Virus Infection in Russia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Cost Effectiveness Analysis of Sofosbuvir and Ledipasvir/Sofosbuvir in Hepatitis C Virus (HCV) Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

A Cost-Effectiveness Analysis of Shortened Direct-Acting Antiviral Treatment in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virus

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2019English

Cost-Effectiveness of Access Expansion to Treatment of Hepatitis C Virus Infection Through Primary Care Providers

Gastroenterology
HepatologyGastroenterology
2017English

Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis-C Virus Infection in Venezuela

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

The Cost-Effectiveness of Hepatitis C Treatments in Treatment Naïve Genotype 1 Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Hepatitis C Virus Treatment Update

Sohag Medical Journal
2019English

Cost-Effectiveness of Universal Hepatitis C Virus Screening of Pregnant Women in the United States

Clinical Infectious Diseases
Infectious DiseasesMicrobiology
2019English

Cost Effectiveness of Fibrosis Assessment Prior to Treatment for Chronic Hepatitis C Patients

PLoS ONE
Multidisciplinary
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy